On August 30, 2019 Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, reported that management will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference to be held September 8-10, 2019, at the Lotte New York Palace Hotel in New York City (Press release, Amyris Biotechnologies, AUG 30, 2019, https://www.prnewswire.com/news-releases/amyris-to-present-at-hc-wainwright-21st-annual-global-investment-conference-on-september-9-2019-300909518.html [SID1234539155]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Amyris will provide an update on the progress and performance of its business during the presentation, which is scheduled for Monday, September 9, at 9:10 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at View Source